These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F. Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256 [Abstract] [Full Text] [Related]
11. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia. Kondo LM, Wittkowsky AK, Wiggins BS. Ann Pharmacother; 2001 Apr 10; 35(4):440-51. PubMed ID: 11302409 [Abstract] [Full Text] [Related]
12. Argatroban therapy in women with heparin-induced thrombocytopenia. Jang IK, Baron SJ, Hursting MJ, Anglade E. J Womens Health (Larchmt); 2007 Apr 10; 16(6):895-901. PubMed ID: 17678460 [Abstract] [Full Text] [Related]
13. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy. Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT. Ann Pharmacother; 2005 Oct 10; 39(10):1601-5. PubMed ID: 16131539 [Abstract] [Full Text] [Related]
14. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L. Am J Ther; 2011 Jan 10; 18(1):14-22. PubMed ID: 21079512 [Abstract] [Full Text] [Related]
15. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study. Saugel B, Phillip V, Moessmer G, Schmid RM, Huber W. Crit Care; 2010 Jan 10; 14(3):R90. PubMed ID: 20487559 [Abstract] [Full Text] [Related]
16. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia. Guzzi LM, McCollum DA, Hursting MJ. J Thromb Thrombolysis; 2006 Dec 10; 22(3):169-76. PubMed ID: 17103051 [Abstract] [Full Text] [Related]
17. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia. Hursting MJ, Lewis BE, Macfarlane DE. Clin Appl Thromb Hemost; 2005 Jul 10; 11(3):279-87. PubMed ID: 16015413 [Abstract] [Full Text] [Related]
18. Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban. Hursting MJ, Jang IK. J Thromb Thrombolysis; 2009 Jul 10; 28(1):10-5. PubMed ID: 19016311 [Abstract] [Full Text] [Related]
19. Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban. Haas S, Lewis B. Int Angiol; 2011 Dec 10; 30(6):541-6. PubMed ID: 22233615 [Abstract] [Full Text] [Related]
20. Argatroban in the management of heparin-induced thrombocytopenia. Babuin L, Pengo V. Vasc Health Risk Manag; 2010 Sep 07; 6():813-9. PubMed ID: 20859550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]